KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Goodwill (2016 - 2025)

Historic Goodwill for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to $35.6 billion.

  • AbbVie's Goodwill rose 93.78% to $35.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $35.6 billion, marking a year-over-year increase of 93.78%. This contributed to the annual value of $35.0 billion for FY2024, which is 824.64% up from last year.
  • According to the latest figures from Q3 2025, AbbVie's Goodwill is $35.6 billion, which was up 93.78% from $35.6 billion recorded in Q2 2025.
  • AbbVie's 5-year Goodwill high stood at $35.6 billion for Q2 2025, and its period low was $31.7 billion during Q3 2022.
  • Its 5-year average for Goodwill is $33.2 billion, with a median of $32.3 billion in 2021.
  • The largest annual percentage gain for AbbVie's Goodwill in the last 5 years was 10788.51% (2021), contrasted with its biggest fall of 2454.38% (2021).
  • AbbVie's Goodwill (Quarter) stood at $32.4 billion in 2021, then decreased by 0.69% to $32.2 billion in 2022, then grew by 0.43% to $32.3 billion in 2023, then rose by 8.25% to $35.0 billion in 2024, then grew by 1.92% to $35.6 billion in 2025.
  • Its Goodwill was $35.6 billion in Q3 2025, compared to $35.6 billion in Q2 2025 and $35.3 billion in Q1 2025.